Retrospective study finds significant reductions in glucose metabolism indicators in type 2 diabetes, suggesting digital management tools may enhance care.
Background: Accurate biochemical monitoring is central to effective diabetes management. This study investigated the effect of the National Standardized Metabolic Management Center (MMC)-assisted glycemic control assistant on laboratory-based glucose metabolism parameters in patients with type 2 diabetes. Methods: A retrospective study was conducted on 160 patients with type 2 diabetes, including 95 who received MMC-assisted digital management and 65 who received routine care. Key biochemical parameters—fasting plasma glucose (FPG), 2-hour postprandial glucose (2hPG), and glycated hemoglobin (HbA1c)—were measured using standardized enzymatic assays. Dietary behavior and diabetes self-management were also assessed using validated scales. Results: Baseline biochemical markers and behavioral scores showed no significant differences between groups. After intervention, the MMC-assisted group demonstrated significantly lower levels of FPG (7.42±2.43 vs. 8.30±2.66 mmol/L, P=0.032), 2hPG (10.23±3.21 vs. 12.39±3.50 mmol/L, P<0.001), and HbA1c (7.26±2.05% vs. 7.98±2.34%, P=0.041) compared to controls. Improvements were also observed in dietary behavior and self-management, including better adherence to blood glucose monitoring and medication. Conclusion: The MMC-assisted glycemic control assistant significantly improves biochemical markers of glucose metabolism in patients with type 2 diabetes. This laboratory-confirmed improvement supports the integration of digital tools into standardized metabolic disease management.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: